Dechra Isaderm Vet. Gel til hund

Isaderm Vet. is a prescription veterinary topical gel formulated for dogs, containing fusidic acid and betamethasone to treat acute moist dermatitis (hot spots). The formulation has historical roots tied to Danish pharmaceutical research into fusidic acid (developed by LEO Pharma/Leo Animal Health).

Today, the product is marketed and distributed by Dechra Pharmaceuticals, an international veterinary pharmaceutical company founded in the United Kingdom. In early 2024, Dechra Pharmaceuticals was acquired by the global private equity investment firm EQT, based in Sweden, alongside co-investor Luxinva (a wholly owned subsidiary of ADIA). Manufacturing of Dechra's topical dermatological products, including Isaderm, takes place at specialized veterinary pharmaceutical manufacturing facilities, primarily located in Denmark and the UK.